Age-stratified CD19+ B-cell reference values in children and adolescents—a systematic review and meta-analysis
Journal of Allergy and Clinical Immunology · 2026-09
DOI: 10.1016/j.jaci.2026.07.027 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026-09. Verfasst von Diana Ljung Sass und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Pediatrics, Institute of Clinical Sciences, Sahl…. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Barncancerfonden, Västra Götalandsregionen.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND: Accurate monitoring of B-cell reconstitution is dependent on age-specific pediatric reference ranges. However, pediatric CD19+ B-cell reference values currently lack harmonization and are inconsistently defined. OBJECTIVE: We sought to systematically evaluate published pediatric reference values for CD19+ B cells in healthy children and adolescents (age range, 0-18 years). METHODS: This review and meta-analysis was conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) 2020 guidelines. A comprehensive literature search was performed for studies reporting CD19+ B cells in healthy children from 2000 to 2025 (final search in March 2025). Records were independently screened and assessed for quality by 3 investigators. Data for lower limit of normal (lower limit of 95% reference interval) were analyzed and compared for different age groups. RESULTS: After screening, 29 publications met the inclusion criteria, representing a total cohort of 10,399 individuals. Our analysis showed that the lower limit of normal of CD19+ B-cell values differed according to the age of the child. We identified 5 distinct age groups and corresponding values of lower limit of normal. In children younger than 6 years, B-cell values were consistently different from values that have been reported for adults. CONCLUSION: This systematic synthesis summarizes consolidated age-stratified lower limits of normal values for CD19+ B cells in children and adolescents. Proposed CD19+ B-cell values can be used for standardized clinical monitoring of B-cell recovery to normal values after CD19-depleting therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Electro…
- Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Clinical Immunology and Transfusion Medicine, Sahlgrenska Uni…
- School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
- Department of Pediatric Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Förderung
- Barncancerfonden
- Västra Götalandsregionen
Zitieren
APA
Ljung Sass, D., Camponeschi, A., Pettersson, M., & Mellgren, K. (2026). Age-stratified CD19+ B-cell reference values in children and adolescents—a systematic review and meta-analysis. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2026.07.027
Vancouver
Ljung Sass D, Camponeschi A, Pettersson M, Mellgren K. Age-stratified CD19+ B-cell reference values in children and adolescents—a systematic review and meta-analysis. Journal of Allergy and Clinical Immunology. 2026. doi:10.1016/j.jaci.2026.07.027
BibTeX
@article{LjungSass2026,
author = {Ljung Sass, Diana and Camponeschi, Alessandro and Pettersson, Magnus and Mellgren, Karin},
title = {Age-stratified CD19+ B-cell reference values in children and adolescents—a systematic review and meta-analysis},
journal = {Journal of Allergy and Clinical Immunology},
year = {2026},
doi = {10.1016/j.jaci.2026.07.027}
}
EUVIMED